Advertisement

Nitroglyzerininduzierte endotheliale Dysfunktion und Nitrattoleranz

  • John D. Parker
Chapter
  • 20 Downloads

Zusammenfassung

Seit über 120 Jahren gehören Nitrate zum therapeutischen Schatz bei der Behandlung von ischämischen Herzerkrankungen, insbesondere bei der koronaren Herzkrankheit. Ihr Einsatz und Stellenwert ist in nationalen und internationalen Leitlinien beschrieben. Die akute Gabe von organischen Nitraten hat einen starken Effekt auf
  • Blutdruck

  • Füllungsdruck

  • Belastungskapazität

  • akute Angina-pectoris-Symptomatik

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Elkayam U (1991) Tolerance to organic nitrates: evidence, mechanisms, clinical relevance, and strategies for prevention. Ann Intern. Med. 114: 667–677PubMedGoogle Scholar
  2. 2.
    Abrams J (1988) A reappraisal of nitrate therapy. JAMA (J Am Med Assoc) 259: 396–401CrossRefGoogle Scholar
  3. 3.
    Chung SH, Fung HL (1990) Identification of a subcellular site for nitroglyerin metabolism to nitric oxide in bovine coronary smooth muscle cells. J Pharmacol Exp. Ther 253: 614–619PubMedGoogle Scholar
  4. 4.
    Dupuis J, Lalonde G, Lemieux R, Rouleau JL (1990) Tolerance to intravenous nitroglycerin in patients with congestive heart failure: role of increased intrayscular volume, neurohumoral activation and lack of prevention with N-acetylcysteine. J Am Coll Cardiol 16: 923–931PubMedCrossRefGoogle Scholar
  5. 5.
    Packer M, Lee W, Kessler P D, Gottlieb S S, Medina N, Yushak M (1987) Prevention and reversal of nitrate tolerance in patients with congestive heart failure. N Engl J Med 317: 799–804PubMedCrossRefGoogle Scholar
  6. 6.
    Parker J D, Farrel B, Fenton T, Cohanim M, Parker JO (1991) Counter-regulatory responses to continuous and intermittent therapy with nitroglycerin. Circulation 84: 2336–2345PubMedCrossRefGoogle Scholar
  7. 7.
    Molina CR, Andresen JW, Rapoport RM, Saldman S, Murad F (1987) Effect of in vivo nitroglycerin therapy on endothelium-dependent and independend vascular relaxation and cyclic GMP accumulation in rat aorta. J Cardiovasc Pharmacol 10: 371–378PubMedCrossRefGoogle Scholar
  8. 8.
    Axelsson KL, Anderson RG (1983) Tolerance towards nitroglycerin, induced in vivo, is correlated to a reduced cGMP response and an alteration in CGMP turnover Eur J Pharmacol 88: 71–79PubMedCrossRefGoogle Scholar
  9. 9.
    Münzel T, Sayegh H, Freeman B A, Tarpy M M, Harrison DG (1995) Endivence for Enhanced Vascular Superoxide Anion Production in Nitrate Tolerance. J Clin Invest 95: 187–194PubMedCrossRefGoogle Scholar
  10. 10.
    Ting HH, Timimi FK, Haley EA, Roddy M-A, Ganz P, Creager MA (1997) Vitamin C Improves Endothelium-Dependent Vasodilatation in Forearm Resistance Vessels of Humans with Hypercholesterolemia. Circulation 95: 2617–2622PubMedCrossRefGoogle Scholar
  11. 11.
    Gori T, Mak SS, Kelly S, Parker JD (2001) Evidence Supporting Abnormalities in Nitric Oxide Synthase Function Induced by Nitroglycerin in Humans. J Am Coll Cardiol 38 (4): 1096–1101PubMedCrossRefGoogle Scholar
  12. 12.
    Caramori RP, Adelman AG, Azevedo ER, Newton GE, Parker AB, Parker JD (1998) Therapy with nitroglycerin increases coronary vasoconstriction in response to acetylcholine. J Am Coll Cardiol 32: 1969–1974PubMedCrossRefGoogle Scholar
  13. 13.
    Gori T, Burstein J, Ahmed S et al (2001) Folic acid prevents nitroglycerin induced nitric oxide synthase dysfunction and nitrate tolerance: a human in vivo study. Circulation 104 (1): 119–123CrossRefGoogle Scholar
  14. 14.
    Gruhn N, Aldershvile J, Boesgard S (2001) Tetrahydrobiopterin improves endothelium dependent Vasodilatation in nitroglycerin-tolerant rats. Eur J Pharmacol 416: 245–249PubMedCrossRefGoogle Scholar
  15. 15.
    Fink B, Bassenge E (1997) Unexpected, Tolerance-Devoid Vasomotor and Platelet Actions of Pentaerithrityl Tetranitrate. J Cardiovasc Pharmacol 30: 831–836PubMedCrossRefGoogle Scholar
  16. 16.
    Jurt U, Gori T, Ravand A, Babaei S, Zeman P, Parker J D (2001) Differential Effects of Pentaerythritol Tetranitrate and Nitroglycerin on the Development of Tolerance and Evidence of Lipid Peroxidation: A Human In Vivo Study. J Am Coll Cardiol 38: 854–859PubMedCrossRefGoogle Scholar
  17. 17.
    Patrono C, FitzGerald GA (1997) Isoprostanes: potential markers of oxidant stress in atherothrombotic disease. Arterioscler Thromb Vasc Biol 17: 2309–2315PubMedCrossRefGoogle Scholar
  18. 18.
    Hacker A, Müller S, Mayer W, Kojda G (2001) The nitric oxide donor pentaerythritol tetranitrate can preserve endothelial function in established atherosclerosis. Brit J Pharmacol 132 (8): 1707–1714CrossRefGoogle Scholar

Copyright information

© Steinkopff Verlag Darmstadt 2004

Authors and Affiliations

  • John D. Parker

There are no affiliations available

Personalised recommendations